All known effects of cyclic AMP in eukaryotic cells result from which of the following?
The IP3/DAG pathway is activated by which of the following?
Second messengers, DAG and IP3, are formed from which of the following?
Steroid hormones exert their effects by binding to which of the following?
Which of the following is not a hydrophobic secondary messenger?
Which of the following is a second messenger?
All of the following have receptors which are transcription factors, except?
Which of the following binds to a Tyrosine Kinase receptor?
Which receptor has intrinsic enzymatic activity?
Members of the multi-pass, G protein-linked family of receptors include the muscarinic cholinergic and $\beta$-adrenergic receptors and rhodopsin. Which of the following characterizes these receptors?
Explanation: ### Explanation **Core Concept: The cAMP-PKA Pathway** In eukaryotic cells, cyclic AMP (cAMP) acts as a classic **second messenger**. Its primary and almost universal mechanism of action is the activation of **Protein Kinase A (PKA)**. PKA is a heterotetramer consisting of two regulatory (R) subunits and two catalytic (C) subunits. When cAMP levels rise, four molecules of cAMP bind to the regulatory subunits. This causes a conformational change that leads to the dissociation of the catalytic subunits. Once free, these catalytic subunits phosphorylate specific serine and threonine residues on target proteins (enzymes or transcription factors like CREB), thereby altering cellular activity. **Analysis of Options:** * **Option A (Incorrect):** Adenylate cyclase is the enzyme that *produces* cAMP from ATP. It is activated by G-proteins (Gs), not by cAMP itself. This would be a circular logic error. * **Option B (Incorrect):** While cAMP can eventually lead to the activation of certain synthetases (via phosphorylation cascades), it does not bind to or activate them directly. * **Option D (Incorrect):** G-proteins are regulated by the exchange of GDP for GTP and their intrinsic GTPase activity. They are upstream of cAMP production, not downstream targets of cAMP phosphorylation. **NEET-PG High-Yield Pearls:** * **Termination:** The signal of cAMP is terminated by **Phosphodiesterase (PDE)**, which converts cAMP to 5'-AMP. Drugs like Caffeine and Theophylline inhibit PDE, prolonging cAMP action. * **Exceptions:** While PKA is the primary target, cAMP can also directly modulate **HCN channels** (in the heart) and **Epac** (Exchange protein directly activated by cAMP), though PKA remains the "best" answer for general eukaryotic effects. * **Vibrio cholerae:** Cholera toxin causes permanent activation of Gs, leading to constitutive cAMP production and massive secretory diarrhea.
Explanation: **Explanation:** The **IP3/DAG pathway** is a major signal transduction mechanism used by hormones like Oxytocin, Vasopressin (V1), and GnRH. **1. Why Phospholipase C (PLC) is correct:** When a ligand binds to a Gq-protein-coupled receptor (GPCR), it activates the enzyme **Phospholipase C**. PLC acts on the membrane phospholipid **Phosphatidylinositol 4,5-bisphosphate (PIP2)**, cleaving it into two secondary messengers: * **Inositol triphosphate (IP3):** Water-soluble; binds to receptors on the endoplasmic reticulum to release intracellular **Calcium (Ca²⁺)**. * **Diacylglycerol (DAG):** Lipid-soluble; remains in the membrane to activate **Protein Kinase C (PKC)**. **2. Why other options are incorrect:** * **Protein Kinase A (PKA):** Activated by cAMP in the Gs/Gi pathways, not the IP3/DAG pathway. * **Protein Kinase C (PKC):** This is an **effector** activated *by* DAG; it does not activate the pathway itself. * **Phospholipase A (PLA2):** This enzyme cleaves phospholipids to release **Arachidonic acid**, the precursor for prostaglandins and leukotrienes (eicosanoid synthesis). **Clinical Pearls for NEET-PG:** * **Mnemonic for Gq-coupled receptors:** "H1, Alpha-1, V1, M1, M3" (The **HAV 1 M&M** receptors). * **Lithium's mechanism:** Lithium inhibits the recycling of inositol (Inositol monophosphatase), thereby interfering with the IP3/DAG cycle—this is its primary mechanism in treating Bipolar Disorder. * **Calcium-Calmodulin complex:** Released Ca²⁺ (via IP3) binds to Calmodulin to activate various intracellular enzymes.
Explanation: ### Explanation The correct answer is **Phosphatidyl inositol**. **1. Why Phosphatidyl Inositol is Correct:** The signal transduction pathway involving **IP3 (Inositol triphosphate)** and **DAG (Diacylglycerol)** begins when a hormone or ligand binds to a G-protein coupled receptor (GPCR), specifically the **Gq** subtype. This activates the enzyme **Phospholipase C (PLC)**. PLC cleaves a specific membrane phospholipid called **Phosphatidylinositol 4,5-bisphosphate (PIP2)**—a derivative of phosphatidyl inositol. * **IP3** is water-soluble and diffuses into the cytosol to trigger the release of **Calcium (Ca²⁺)** from the endoplasmic reticulum. * **DAG** remains in the membrane and activates **Protein Kinase C (PKC)**. **2. Why Other Options are Incorrect:** * **Phosphatidyl choline (Lecithin):** The most abundant phospholipid in the cell membrane and a major component of lung surfactant. While it can be a source of second messengers in some pathways, it is not the precursor for the IP3/DAG signaling cascade. * **Phosphatidyl ethanolamine (Cephalin):** A structural phospholipid found primarily in the inner leaflet of the plasma membrane; it does not serve as a precursor for IP3/DAG. * **Phosphatidyl serine:** Primarily involved in cell signaling related to **apoptosis** (when it flips to the outer leaflet, it acts as an "eat-me" signal for macrophages). **3. High-Yield Clinical Pearls for NEET-PG:** * **Gq-Protein mnemonic:** Remember "**HAV 1 M&M**" (Histamine-1, Alpha-1, Vasopressin-1, Muscarinic-1, and Muscarinic-3 receptors) all use the Gq/PLC/IP3-DAG pathway. * **Lithium Connection:** Lithium (used in Bipolar Disorder) inhibits the recycling of inositol (Inositol monophosphatase), thereby depleting PIP2 levels and dampening overactive signaling. * **Calcium** is often considered the "third messenger" in this specific pathway.
Explanation: **Explanation:** **Why Transcription Factors are the Correct Answer:** Steroid hormones (e.g., Cortisol, Estrogen, Testosterone) are lipophilic molecules derived from cholesterol. Due to their hydrophobic nature, they easily diffuse across the lipid bilayer of the plasma membrane. Once inside the cell, they bind to specific **intracellular receptors** (located in the cytoplasm or nucleus). The hormone-receptor complex then translocates into the nucleus, where it binds to specific DNA sequences known as **Hormone Response Elements (HREs)**. In this capacity, the hormone-receptor complex acts as a **ligand-activated transcription factor**, directly modulating the gene expression (mRNA synthesis) that leads to the synthesis of new proteins. **Why Other Options are Incorrect:** * **A. Cell surface receptors:** These are typically used by hydrophilic hormones (e.g., Peptide hormones, Catecholamines) that cannot cross the cell membrane. * **B. G proteins:** These are membrane-associated proteins that act as molecular switches for G-Protein Coupled Receptors (GPCRs), not for steroid signaling. * **D. cAMP:** This is a second messenger used by hormones that bind to surface receptors (like Glucagon or ACTH) to trigger a phosphorylation cascade. Steroid hormones do not require second messengers as they act directly on DNA. **High-Yield Clinical Pearls for NEET-PG:** * **Exceptions to the Rule:** While most steroid receptors are cytoplasmic (e.g., Glucocorticoids), **Estrogen and Progesterone** receptors are primarily nuclear. **Thyroid hormones (T3/T4)**, though not steroids, also use this mechanism and have receptors already bound to DNA. * **Speed of Action:** Steroid signaling is **slow** (hours to days) because it requires protein synthesis, whereas GPCR signaling is **fast** (seconds) because it modifies existing proteins. * **Zinc Fingers:** The DNA-binding domain of steroid receptors often contains "Zinc Finger" motifs, a common structural requirement for binding to the major groove of DNA.
Explanation: **Explanation:** The classification of secondary messengers is based on their solubility and location within the cell. They are broadly divided into **hydrophilic (water-soluble)**, **hydrophobic (lipid-soluble)**, and **gases**. **Why cAMP is the correct answer:** **Cyclic AMP (cAMP)** is a **hydrophilic** secondary messenger. It is derived from ATP by the action of Adenylate Cyclase and functions within the aqueous environment of the cytosol to activate Protein Kinase A (PKA). Because it dissolves in the cytoplasm and does not reside within the lipid bilayer, it is not a hydrophobic messenger. **Analysis of incorrect options:** * **DAG (Diacylglycerol):** This is a classic **hydrophobic** messenger. It is a lipid molecule that remains tethered to the inner leaflet of the plasma membrane, where it activates Protein Kinase C (PKC). * **IP3 (Inositol triphosphate):** While IP3 is water-soluble and diffuses through the cytosol to the ER, the question asks to identify which is *not* hydrophobic. In many standard classifications, IP3 and DAG are discussed together as products of PIP2 hydrolysis. However, compared to cAMP, **Phosphatidylinositol (Option C)** and its derivatives are lipid-linked. * **Phosphatidylinositol:** This is a membrane phospholipid and the precursor to various signaling molecules (like PIP2 and PIP3). Being a phospholipid, it is inherently **hydrophobic** and integrated into the cell membrane. **NEET-PG High-Yield Pearls:** 1. **Hydrophilic Messengers:** cAMP, cGMP, IP3, and Calcium ($Ca^{2+}$). 2. **Hydrophobic Messengers:** DAG, Phosphatidylinositols, and Lysophosphatidic acid. 3. **Gaseous Messengers:** Nitric Oxide (NO) and Carbon Monoxide (CO). 4. **Enzyme Fact:** cAMP is degraded by **Phosphodiesterase (PDE)**; inhibition of PDE (e.g., by Theophylline or Sildenafil for cGMP) prolongs the messenger's action. 5. **G-Protein Link:** cAMP is typically associated with $G_s$ and $G_i$ pathways, while the IP3/DAG pathway is associated with $G_q$.
Explanation: **Explanation:** Signal transduction involves extracellular signaling molecules (first messengers) binding to cell surface receptors, which triggers the release of intracellular molecules known as **second messengers**. These molecules amplify the signal and initiate a physiological response. **Why cAMP is the correct answer (in the context of this specific question):** While all options listed are technically second messengers, **Cyclic Adenosine Monophosphate (cAMP)** is the most classic and frequently tested example. It is synthesized from ATP by the enzyme **Adenylyl Cyclase** upon activation of G-protein coupled receptors (GPCRs), specifically the $G_s$ subtype. It primarily acts by activating **Protein Kinase A (PKA)**. **Analysis of Options:** * **B, C, and D (cGMP, $IP_3$, and DAG):** These are all valid second messengers. However, in multiple-choice questions where all options are technically correct, the "best" answer often refers to the most ubiquitous or the one specifically associated with the primary pathway being tested. *Note: In many standardized exams, if "All of the above" is not an option, cAMP is considered the prototype second messenger.* **High-Yield NEET-PG Clinical Pearls:** 1. **$IP_3$ and DAG:** These are products of Phospholipase C (PLC) cleavage of $PIP_2$. $IP_3$ mobilizes calcium from the endoplasmic reticulum, while DAG activates Protein Kinase C (PKC). 2. **cGMP:** Utilized by Nitric Oxide (NO) and Atrial Natriuretic Peptide (ANP). It activates Protein Kinase G (PKG) and is degraded by Phosphodiesterase-5 (PDE-5)—the target of Sildenafil. 3. **Calcium:** Often considered a "third messenger" or a unique second messenger that binds to **Calmodulin**. 4. **Hormones using cAMP:** Glucagon, ACTH, PTH, TSH, and ADH ($V_2$ receptors).
Explanation: ### Explanation The question tests the classification of hormone receptors based on their location and mechanism of action. **1. Why Insulin is the Correct Answer:** Insulin acts via a **Cell Surface Receptor**, specifically a **Receptor Tyrosine Kinase (RTK)**. When insulin binds to the extracellular alpha subunits, it triggers autophosphorylation of the intracellular beta subunits. This initiates a phosphorylation cascade (PI3K and MAPK pathways) to mediate metabolic effects and gene expression. It does **not** function as a direct transcription factor. **2. Analysis of Incorrect Options (Intracellular Receptors):** Options B, C, and D belong to the **Group I hormones**, which are lipophilic and can cross the plasma membrane. Their receptors are **Transcription Factors** located in the cytosol or nucleus: * **Estrogen & Glucocorticoids:** Bind to nuclear/cytoplasmic receptors. Once the hormone-receptor complex forms, it translocates to the nucleus, binds to specific **Hormone Response Elements (HRE)** on DNA, and directly regulates gene transcription. * **Vitamin D:** Binds to the Vitamin D Receptor (VDR) in the nucleus, which then heterodimerizes with the Retinoid X Receptor (RXR) to act as a transcription factor. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mnemonic for Intracellular Receptors:** **"PET TV"** (Progesterone, Estrogen, Testosterone, Thyroid hormones, Vitamin D/A) + Glucocorticoids/Mineralocorticoids. * **Insulin Receptor Structure:** It is a heterotetramer ($\alpha_2\beta_2$) linked by disulfide bonds. * **cAMP Second Messenger:** Used by Glucagon, ACTH, and PTH (Group II hormones). * **cGMP Second Messenger:** Used by ANP and Nitric Oxide. * **Zinc Fingers:** This is the most common DNA-binding structural motif found in steroid hormone receptors (transcription factors).
Explanation: **Explanation:** The correct answer is **Insulin**. Insulin acts through a **Receptor Tyrosine Kinase (RTK)**, which is a transmembrane protein with intrinsic enzymatic activity. Upon insulin binding, the receptor undergoes autophosphorylation on tyrosine residues, which then triggers a signaling cascade involving Insulin Receptor Substrates (IRS-1/2) and the PI3K/Akt pathway. This is a high-yield concept as it distinguishes metabolic hormones from those using secondary messengers. **Analysis of Incorrect Options:** * **Luteinizing Hormone (LH) & Thyroid-Stimulating Hormone (TSH):** Both are glycoprotein hormones that bind to **G-Protein Coupled Receptors (GPCRs)**. Specifically, they activate the **Gs-adenylyl cyclase-cAMP** pathway. * **Thyrotropin-Releasing Hormone (TRH):** This hypothalamic hormone also binds to a **GPCR**, but it utilizes the **Gq-phospholipase C (PLC)** pathway, leading to an increase in Inositol triphosphate (IP3) and Diacylglycerol (DAG). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for RTK:** "The **PIG** **G**rows **F**ast" (**P**rolactin*, **I**nsulin, **G**rowth Hormone*, **G**rowth **F**actors like EGF, PDGF). * *Note: GH and Prolactin use JAK-STAT (Receptor-associated Tyrosine Kinase), while Insulin and EGF use Intrinsic Tyrosine Kinase.* * **Insulin Receptor Structure:** It is a heterotetramer ($\alpha_2\beta_2$). The $\alpha$-subunits are extracellular (binding site), and the $\beta$-subunits are transmembrane (catalytic site). * **GLUT4:** The PI3K pathway activated by the insulin receptor is responsible for the translocation of GLUT4 to the cell membrane in muscle and adipose tissue.
Explanation: ### Explanation **1. Why Insulin Receptor is Correct:** The **Insulin receptor** is a classic example of a **Receptor Tyrosine Kinase (RTK)**. These are transmembrane proteins that possess **intrinsic enzymatic activity**. Upon binding of insulin to the extracellular $\alpha$-subunits, a conformational change occurs in the intracellular $\beta$-subunits. This triggers **autophosphorylation** of tyrosine residues, which then activates downstream signaling molecules like Insulin Receptor Substrate (IRS-1), leading to the metabolic effects of insulin. **2. Why Other Options are Incorrect:** * **Progesterone Receptor (Option B):** This is a **Nuclear Receptor**. Progesterone is a steroid hormone that is lipophilic; it crosses the cell membrane and binds to receptors in the cytoplasm or nucleus, which then act as ligand-activated transcription factors. * **Thyroxine Receptor (Option C):** This is also a **Nuclear Receptor**. Thyroid hormones (T3/T4) bind to receptors already located on the DNA in the nucleus to regulate gene expression. * **Glucagon Receptor (Option D):** This is a **G-Protein Coupled Receptor (GPCR)**. It does *not* have intrinsic enzymatic activity. Instead, it activates an intermediary membrane-bound enzyme, **Adenylate Cyclase**, via a Gs-protein to produce the second messenger cAMP. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Other RTKs:** Receptors for IGF-1, EGF, PDGF, and FGF also possess intrinsic tyrosine kinase activity. * **JAK-STAT Pathway:** Receptors for Growth Hormone and Prolactin do **not** have intrinsic activity; they recruit soluble kinases (Janus Kinase) to signal. * **Insulin Resistance:** Often involves defects in the post-receptor signaling pathway (e.g., serine phosphorylation of IRS-1 instead of tyrosine phosphorylation). * **Mnemonic:** "Intrinsic" = Insulin, IGF, Growth Factors (except GH).
Explanation: **Explanation:** The receptors mentioned (muscarinic cholinergic, $\beta$-adrenergic, and rhodopsin) belong to the **G Protein-Coupled Receptor (GPCR)** superfamily, also known as **7-transmembrane (7-TM) or serpentine receptors**. **Why Option B is Correct:** GPCRs function by acting as molecular switches. When a ligand binds to the extracellular domain, the receptor undergoes a conformational change that activates an associated heterotrimeric G protein ($\alpha, \beta, \gamma$ subunits). The activated G protein subunits then dissociate to modulate the activity of **effector proteins**. These effectors are typically **plasma membrane-bound enzymes** (e.g., Adenylyl Cyclase, Phospholipase C) or **ion channels** (e.g., $K^+$ channels in the heart via $M_2$ receptors), leading to the generation of second messengers like cAMP, $IP_3$, and $DAG$. **Analysis of Incorrect Options:** * **Option A:** GPCRs are **multi-pass** proteins that traverse the membrane **seven times** as alpha-helices, not once. Single-pass receptors are typical of Enzyme-linked receptors (e.g., Insulin receptor). * **Option C:** These receptors have an **extracellular** ligand-binding domain. Intracellular receptors are characteristic of steroid hormones, thyroid hormones, and Vitamin D. * **Option D:** GPCRs **lack intrinsic enzyme activity**. They rely on G proteins to signal to separate effector enzymes. Receptors with intrinsic activity include Receptor Tyrosine Kinases (e.g., Insulin, EGF). **High-Yield Clinical Pearls for NEET-PG:** * **Gq Pathway:** $M_1, M_3, \alpha_1$ receptors $\rightarrow$ Phospholipase C $\rightarrow \uparrow IP_3/DAG \rightarrow \uparrow Ca^{2+}$. * **Gs Pathway:** $\beta_1, \beta_2, D_1$ receptors $\rightarrow \uparrow$ Adenylyl Cyclase $\rightarrow \uparrow$ cAMP. * **Gi Pathway:** $M_2, \alpha_2, D_2$ receptors $\rightarrow \downarrow$ Adenylyl Cyclase $\rightarrow \downarrow$ cAMP. * **Vibrio cholerae toxin** causes permanent activation of Gs (via ADP-ribosylation), leading to persistent high cAMP and secretory diarrhea.
Cell Surface Receptors: Types and Functions
Practice Questions
G-Protein Coupled Receptors
Practice Questions
Enzyme-Linked Receptors
Practice Questions
Second Messengers in Signal Transduction
Practice Questions
cAMP and cGMP Signaling
Practice Questions
Calcium as Second Messenger
Practice Questions
Inositol Phosphate Pathway
Practice Questions
MAP Kinase Cascades
Practice Questions
JAK-STAT Signaling Pathway
Practice Questions
Insulin Signaling Pathway
Practice Questions
Nuclear Receptors and Gene Regulation
Practice Questions
Defects in Signal Transduction and Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free